https://www.selleckchem.com/pr....oducts/Novobiocin-so
51, 95% CI 1.44-1.58) and in participants without diabetes mellitus (aHR 1.36, 95% CI 1.33-1.39), hypertension (aHR 1.38, 95% CI 1.34-1.42), or dyslipidemia (aHR 1.35, 95% CI 1.32-1.38). Compared with the control population, patients who underwent cholecystectomy exhibited an increased incidence of MDD. Thus, physicians should implement an enhanced program of MDD screening for at least several years after cholecystectomy. Compared with the control population, patients who underwent cholecystectomy exhibited an incre
Like
Comment
Share
